Reveal the Patterns of Presentation, Management and Outcome of Patients With SCLC and Stage III NSCLC in Saudi Arabia:
Clinical trial NCT04836975 · COMPLETED
Trial details
- NCT number
- NCT04836975
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-02-28
- Primary completion
- 2022-12-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.